Paperpal for Life Sciences Establishes HIPAA Readiness for Regulated Medical Writing

Paperpal for Life Sciences completes a comprehensive assessment of its operational and technical safeguards to support HIPAA requirements, strengthening enterprise adoption of AI in regulated medical and scientific writing workflows. The enterprise-grade AI platform by Cactus Communications now offers the option to execute a Business Associate Agreement for Protected Health Information and Personally Identifiable Information, ensuring data handling meets stringent privacy standards.
This HIPAA readiness milestone addresses growing scrutiny on data privacy, governance, and regulatory accountability as AI integrates into medical affairs content creation. The platform delivers AI writing assistance, literature search capabilities, source-grounded summarization with citation support, and publication readiness checks, accelerating research-to-publication timelines by up to 25% while maintaining compliance.
Medical Affairs and Life Sciences organizations gain confidence deploying AI at scale, knowing PHI and PII receive secure, responsible treatment aligned with enterprise risk management. Paperpal’s secure-by-design approach includes end-to-end encryption, ISO/IEC 27001:2022 certification, GDPR compliance, and CSA STAR Level 1 listing, positioning it as a trusted partner for regulated scientific workflows.
Nishchay Shah, Group CTO at Cactus Communications, emphasizes that compliance and trust form the foundation for AI adoption in regulated environments. Elvira Dsouza, President of Cactus Life Sciences, notes the platform enables faster evidence generation and scientific communication without compromising regulatory integrity.